Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients

NCT00658463 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Rosuvastatin
DRUG: Placebo

Sponsor

Centre Hospitalier Universitaire Dijon

Collaborators

[object Object]